首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   442010篇
  免费   28433篇
  国内免费   1046篇
耳鼻咽喉   5949篇
儿科学   14094篇
妇产科学   13041篇
基础医学   64054篇
口腔科学   10585篇
临床医学   38859篇
内科学   85460篇
皮肤病学   8201篇
神经病学   33793篇
特种医学   17301篇
外国民族医学   46篇
外科学   69512篇
综合类   9932篇
现状与发展   2篇
一般理论   343篇
预防医学   33618篇
眼科学   10145篇
药学   31398篇
  2篇
中国医学   971篇
肿瘤学   24183篇
  2021年   4859篇
  2019年   4779篇
  2018年   6654篇
  2017年   4870篇
  2016年   5408篇
  2015年   6285篇
  2014年   8727篇
  2013年   13501篇
  2012年   18242篇
  2011年   19276篇
  2010年   11627篇
  2009年   10538篇
  2008年   17388篇
  2007年   18827篇
  2006年   18241篇
  2005年   18002篇
  2004年   17390篇
  2003年   16379篇
  2002年   15740篇
  2001年   15048篇
  2000年   15170篇
  1999年   13180篇
  1998年   4782篇
  1997年   4208篇
  1996年   3993篇
  1995年   3878篇
  1994年   3483篇
  1993年   3304篇
  1992年   9503篇
  1991年   9657篇
  1990年   9364篇
  1989年   9093篇
  1988年   8389篇
  1987年   8117篇
  1986年   7745篇
  1985年   7587篇
  1984年   5877篇
  1983年   5157篇
  1982年   3682篇
  1981年   3287篇
  1979年   5245篇
  1978年   4037篇
  1977年   3449篇
  1976年   3143篇
  1975年   3429篇
  1974年   3948篇
  1973年   3939篇
  1972年   3543篇
  1971年   3374篇
  1970年   3229篇
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
1.
2.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome.  相似文献   
3.
4.
5.
Two Janus-associated kinase inhibitors (JAKi) (initially ruxolitinib and, more recently, fedratinib) have been approved as treatment options for patients who have intermediate-risk and high-risk myelofibrosis (MF), with pivotal trials demonstrating improvements in spleen volume, disease symptoms, and quality of life. At the same time, however, clinical trial experiences with JAKi agents in MF have demonstrated a high frequency of discontinuations because of adverse events or progressive disease. In addition, overall survival benefits and clinical and molecular predictors of response have not been established in this population, for which the disease burden is high and treatment options are limited. Consistently poor outcomes have been documented after JAKi discontinuation, with survival durations after ruxolitinib ranging from 11 to 16 months across several studies. To address such a high unmet therapeutic need, various non-JAKi agents are being actively explored (in combination with ruxolitinib in first-line or salvage settings and/or as monotherapy in JAKi-pretreated patients) in phase 3 clinical trials, including pelabresib (a bromodomain and extraterminal domain inhibitor), navitoclax (a B-cell lymphoma 2/B-cell lymphoma 2-xL inhibitor), parsaclisib (a phosphoinositide 3-kinase inhibitor), navtemadlin (formerly KRT-232; a murine double-minute chromosome 2 inhibitor), and imetelstat (a telomerase inhibitor). The breadth of data expected from these trials will provide insight into the ability of non-JAKi treatments to modify the natural history of MF.  相似文献   
6.
7.

Objectives

To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.

Design

Cross-sectional survey.

Method

An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.

Results

Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.

Conclusions

Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号